Newsroom

Newsroom

NeoGenomics Reports 18% Revenue Growth and Strong Gains in Adjusted EBITDA

Press Release
Read More

NeoGenomics Expands Multimodality Cancer Profile Testing

Press Release
Read More

NeoGenomics Launches Germline Cancer Predisposition Testing

Press Release
Read More

NeoGenomics Schedules its Q2 2015 Earnings Release for July 23, 2015

Press Release
Read More

NeoGenomics Announces New Directors

Press Release
Read More

NeoGenomics Set to Join Russell 3000 Index

Press Release
Read More

NeoGenomics Reports 27% Revenue Growth Driven by Strong Volume Gains and PathLogic Acquisition

Press Release
Read More

NeoGenomics Announces Promotions

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients